These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 8437512
1. BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection. Clozel M, Watanabe H. Life Sci; 1993; 52(9):825-34. PubMed ID: 8437512 [Abstract] [Full Text] [Related]
2. The role of endothelin and nitric oxide in modulation of normal and spastic cerebral vascular tone in the dog. Hirose H, Ide K, Sasaki T, Takahashi R, Kobayashi M, Ikemoto F, Yano M, Nishikibe M. Eur J Pharmacol; 1995 Apr 13; 277(1):77-87. PubMed ID: 7635177 [Abstract] [Full Text] [Related]
3. Influence endothelin ETA receptor antagonist--BQ-123--on changes of endothelin-1 level in plasma of rats with acute vasospasm following subarachnoid hemorrhage. Jośko J, Hendryk S, Jedrzejowska-Szypuła H, Gwóźdź B, Herman ZS, Gawlik R. J Physiol Pharmacol; 1998 Sep 13; 49(3):367-75. PubMed ID: 9789790 [Abstract] [Full Text] [Related]
4. Effect of endothelin-1 receptor antagonist BQ-123 on basilar artery diameter after subarachnoid hemorrhage (SAH) in rats. Jośko J, Hendryk S, Jedrzejowska-Szypułka H, Słowiński J, Gwóźdź B, Lange D, Harabin-Słowińska M. J Physiol Pharmacol; 2000 Jun 13; 51(2):241-9. PubMed ID: 10898097 [Abstract] [Full Text] [Related]
5. The effects of endothelin antagonist BQ-610 on cerebral vascular wall following experimental subarachnoid hemorrhage and cerebral vasospasm. Cirak B, Kiymaz N, Ari HH, Ugras S. Clin Auton Res; 2004 Jun 13; 14(3):197-201. PubMed ID: 15241650 [Abstract] [Full Text] [Related]
6. CT perfusion imaging of cerebral microcirculatory changes following subarachnoid hemorrhage in rabbits: Specific role of endothelin-1 receptor antagonist. Wu Q, Zheng R, Wang J, Wang J, Li S. Brain Res; 2018 Dec 15; 1701():196-203. PubMed ID: 30244111 [Abstract] [Full Text] [Related]
8. Prevention of delayed vasospasm by an endothelin ETA receptor antagonist, BQ-123: change of ETA receptor mRNA expression in a canine subarachnoid hemorrhage model. Itoh S, Sasaki T, Asai A, Kuchino Y. J Neurosurg; 1994 Nov 15; 81(5):759-64. PubMed ID: 7931624 [Abstract] [Full Text] [Related]
9. Cerebral angiogenesis after subarachnoid hemorrhage (SAH) and endothelin receptor blockage with BQ-123 antagonist in rats. Jośko J, Hendryk S, Jedrzejowska-Szypułka H, Słowiński J, Gwóźdź B, Lange D, Snietura M, Zwirska-Korczala K, Jochem J. J Physiol Pharmacol; 2001 Jun 15; 52(2):237-48. PubMed ID: 11453103 [Abstract] [Full Text] [Related]
10. Clazosentan, an endothelin receptor antagonist, prevents early hypoperfusion during the acute phase of massive experimental subarachnoid hemorrhage: a laser Doppler flowmetry study in rats. Schubert GA, Schilling L, Thomé C. J Neurosurg; 2008 Dec 15; 109(6):1134-40. PubMed ID: 19035733 [Abstract] [Full Text] [Related]
11. Endothelin B receptor antagonists attenuate subarachnoid hemorrhage-induced cerebral vasospasm. Zuccarello M, Boccaletti R, Romano A, Rapoport RM. Stroke; 1998 Sep 15; 29(9):1924-9. PubMed ID: 9731620 [Abstract] [Full Text] [Related]
12. Effect of endothelinA-receptor antagonist BQ-123 and phosphoramidon on cerebral vasospasm. Cosentino F, McMahon EG, Carter JS, Katusić ZS. J Cardiovasc Pharmacol; 1993 Sep 15; 22 Suppl 8():S332-5. PubMed ID: 7509979 [Abstract] [Full Text] [Related]
13. Decreased endothelium-dependent relaxation in subarachnoid hemorrhage-induced vasospasm: role of ET-1. Zuccarello M, Romano A, Passalacqua M, Rapoport RM. Am J Physiol; 1995 Sep 15; 269(3 Pt 2):H1009-15. PubMed ID: 7573496 [Abstract] [Full Text] [Related]
14. Cerebral angiogenesis and expression of VEGF after subarachnoid hemorrhage (SAH) in rats. Jośko J. Brain Res; 2003 Aug 15; 981(1-2):58-69. PubMed ID: 12885426 [Abstract] [Full Text] [Related]
15. Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm. Wanebo JE, Arthur AS, Louis HG, West K, Kassell NF, Lee KS, Helm GA. Neurosurgery; 1998 Dec 15; 43(6):1409-17; discussion 1417-8. PubMed ID: 9848855 [Abstract] [Full Text] [Related]
16. Prospective, randomized, double-blind trial of BQ-123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys. Hino A, Weir BK, Macdonald RL, Thisted RA, Kim CJ, Johns LM. J Neurosurg; 1995 Sep 15; 83(3):503-9. PubMed ID: 7666230 [Abstract] [Full Text] [Related]
17. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065. Warner TD, Allcock GH, Vane JR. Br J Pharmacol; 1994 May 15; 112(1):207-13. PubMed ID: 8032643 [Abstract] [Full Text] [Related]